State-wise Status of Tuberculosis (TB) Testing on Line Probe Assays (LPA) under National Tuberculosis Elimination Programme (NTEP) in Northern States of India (2022) | ||||||||||
States/UTs | First Line - Line Probe Assay | Second Line - Line Probe Assay | ||||||||
Samples Tested | Susceptible to Both Isoniazid & Rifampicin | Resistant to Both Isoniazid & Rifampicin | Resistant to Rifampicin | Resistant to Isoniazid | Samples Tested | Susceptible to Both FQ & SLI | Resistant to Both FQ & SLI | Resistant to FQ | Resistant to SLI | |
Chandigarh | ||||||||||
Delhi | ||||||||||
Haryana | ||||||||||
Himachal Pradesh | ||||||||||
Jammu & Kashmir | ||||||||||
Ladakh | ||||||||||
Punjab | ||||||||||
Rajasthan | ||||||||||
Uttar Pradesh | ||||||||||
Uttarakhand | ||||||||||
Northern States | ||||||||||
India |